Literature DB >> 34357544

Evaluation of CRISPR/Cas9 System Effects on Knocking Out NEAT1 Gene in AGS Gastric Cancer Cell Line with Therapeutic Perspective.

Nastaran Haghighi1, Abbas Doosti2, Jafar Kiani3.   

Abstract

AIM: Gastric cancer (GC) is one of the most common malignant tumors globally, with an increasing incidence rate. Nuclear paraspeckle assembly transcript 1 (NEAT1) is a long non-coding RNA (lncRNAs) responsible for regulating cell cycle progression, apoptosis, cell growth, proliferation, and migration in various cells. The present survey was performed to assess the effects of NEAT1 gene knocking out by CRISPR/Cas9 system in human gastric cancer cells.
METHODS: The CRISPR/Cas9 genome editing technique was used to knockout NEAT1 in AGS cells as a gastric cancer model. After the design and construction of the vector, transfection was performed. The expression levels of mRNA, the survival of cells, apoptosis, and cell migration were evaluated by real-time quantitative polymerase chain reaction, flow cytometry, and scratch wound.
RESULTS: Degradation of NEAT1 by CRISPR/cas9 significantly suppressed the gene's expression rate, arrested cell cycle in the G0/G1 phase, and a significant reduction in cell number in the S phase (P < 0.05). Degradation of NEAT1 by CRISPR/cas9 also restrained the ability to migrate in transfected cells compared to the control group (P < 0.01). Knockout of NEAT1 via impact on miR-34a gene expression induced apoptosis of AGS cells (P < 0.05) with increasing in the FAS level and total apoptosis (P < 0.001).
CONCLUSIONS: Findings suggest that NEAT1 plays a vital role in cellular mechanisms of GC's occurrence and can serve as a new treatment target in GC.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; CRISPR/Cas9; Gastric cancer; Migration; NEAT1

Mesh:

Substances:

Year:  2021        PMID: 34357544     DOI: 10.1007/s12029-021-00669-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  20 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Long non-coding RNA NEAT1 promotes malignant progression of thyroid carcinoma by regulating miRNA-214.

Authors:  Jian-Hua Li; Su-Qin Zhang; Xing-Guang Qiu; Shui-Jun Zhang; Shou-Hua Zheng; Dan-Hua Zhang
Journal:  Int J Oncol       Date:  2016-12-14       Impact factor: 5.650

Review 3.  Bacteriosomes as a Promising Tool in Biomedical Applications: Immunotherapy and Drug Delivery.

Authors:  Gamaleldin I Harisa; Abdelrahman Y Sherif; Abdullah M E Youssof; Fars K Alanazi; Mounir M Salem-Bekhit
Journal:  AAPS PharmSciTech       Date:  2020-06-08       Impact factor: 3.246

Review 4.  Medicinal plants and cancer chemoprevention.

Authors:  Avni G Desai; Ghulam N Qazi; Ramesh K Ganju; Mahmoud El-Tamer; Jaswant Singh; Ajit K Saxena; Yashbir S Bedi; Subhash C Taneja; Hari K Bhat
Journal:  Curr Drug Metab       Date:  2008-09       Impact factor: 3.731

5.  LncRNA NEAT1 promotes colorectal cancer cell proliferation and migration via regulating glial cell-derived neurotrophic factor by sponging miR-196a-5p.

Authors:  Feng Zhong; Wei Zhang; Yang Cao; Qian Wen; Yue Cao; Bidan Lou; Jinxiang Li; Wenying Shi; Yinghan Liu; Rong Luo; Cheng Chen
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2018-12-01       Impact factor: 3.848

6.  Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients.

Authors:  Chengbiao He; Bing Jiang; Jianrong Ma; Qiaoyu Li
Journal:  APMIS       Date:  2015-11-19       Impact factor: 3.205

Review 7.  The role of microRNAs expression in laryngeal cancer.

Authors:  Xin Yu; Zheng Li
Journal:  Oncotarget       Date:  2015-09-15

8.  NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2.

Authors:  Nan Ding; Haiying Wu; Tao Tao; Erxuan Peng
Journal:  Onco Targets Ther       Date:  2017-10-06       Impact factor: 4.147

Review 9.  Gastric cancer: epidemiology, prevention, classification, and treatment.

Authors:  Robert Sitarz; Małgorzata Skierucha; Jerzy Mielko; G Johan A Offerhaus; Ryszard Maciejewski; Wojciech P Polkowski
Journal:  Cancer Manag Res       Date:  2018-02-07       Impact factor: 3.989

Review 10.  Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors.

Authors:  Peixin Dong; Ying Xiong; Junming Yue; Sharon J B Hanley; Noriko Kobayashi; Yukiharu Todo; Hidemichi Watari
Journal:  Front Genet       Date:  2018-10-15       Impact factor: 4.599

View more
  2 in total

Review 1.  Recent Advances and Therapeutic Strategies Using CRISPR Genome Editing Technique for the Treatment of Cancer.

Authors:  Shreyasi Maity; Rishyani Mukherjee; Satarupa Banerjee
Journal:  Mol Biotechnol       Date:  2022-08-23       Impact factor: 2.860

Review 2.  Using ncRNAs as Tools in Cancer Diagnosis and Treatment-The Way towards Personalized Medicine to Improve Patients' Health.

Authors:  Roberto Piergentili; Giuseppe Basile; Cristina Nocella; Roberto Carnevale; Enrico Marinelli; Renato Patrone; Simona Zaami
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.